Personalized analysis of the genome is a rapidly expanding market. Initially focused on the determination of some risk marker genes, especially cancer, the offer now extends to nutrition in the broad sense. Progress in sequencing has lowered the price of an individual’s entire genome sequencing from $ 100 million in 2001 to $ 10 million…